MedPath

Stangard

Stangard Preventive Treatment Gel

Approved
Approval ID

7cae6a50-ee50-8827-e053-2991aa0a508f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 19, 2022

Manufacturers
FDA

Pascal Company, Inc.

DUNS: 009260217

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Topical SNF Fluoride Gel

PRODUCT DETAILS

NDC Product Code10866-0271
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationDENTAL
Effective DateDecember 19, 2022
Generic NameTopical SNF Fluoride Gel

INGREDIENTS (2)

CARBOMER HOMOPOLYMER TYPE CInactive
Quantity: 12.56 mg in 1 g
Code: 4Q93RCW27E
Classification: IACT
STANNOUS FLUORIDEActive
Quantity: 3.8 mg in 1 g
Code: 3FTR44B32Q
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Stangard - FDA Drug Approval Details